Research work · 2013

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

Luana Calabrò, Aldo Morra, Ester Fonsatti, Ornella Cutaia, Giovanni Amato, Diana Giannarelli, Anna Maria Di Giacomo, Riccardo Danielli, Maresa Altomonte, Luciano Mutti, Michele Maio

The Lancet Oncology

DOI: 10.1016/s1470-2045(13)70381-4